Unlike traditional urology
practices, The Prostatitis and Prostate Cancer Center is focused on disease prevention, improved tools for disease
diagnosis, improved treatment choices when disease is encountered and improved options for treatment failure. This clinic
provides an exceptional blend of traditional and scientifically validated complementary views for all disease without
prejudice. It is well known that prostate disease is epidemic and the number one health risk to men worldwide. Directed by
Dr. Ronald E. Wheeler, a Urologist, The Prostatitis and Prostate Cancer Center evaluates patients from a national,
international and local audience of need.
Patients are counseled during a comprehensive 3-hour visit where no stone is left unturned. Current diagnostic
methodologies, as example, include an evaluation of the expressed prostatic secretion (EPS), the diagnostic test for
Prostatitis (a non-bacterial inflammation of the prostate common in 95% of the cases). Despite the significance of the
EPS, this test is currently performed by fewer than 20% of urologists and the rare family physician. Antibiotics
traditionally prescribed for Prostatitis treatment are rarely successful, suppress the immune system and should not be
used without bacterial culture confirmation.
Additionally, all clinic patients undergo color flow Doppler prostate ultrasound analysis, a promising diagnostic and
prognostic test for patients who have a rising prostate specific antigen (PSA), where biopsy may be offered. No longer is
the "gray scale" (shot in the dark), random, prostate-biopsy approach state of the art for a rising PSA. Patients are
reminded that only 20-30% of all prostate biopsies are positive for cancer. Thus 70-80% of patients receive this invasive
procedure needlessly.
A current randomized double blind study attempts to take patients who have experienced a negative prostate biopsy and
improve their prostate health by lowering their PSA with an all-natural, patented, prostate nutritional formula. This
study expects to change the way patients are selected for biopsy, realizing that the most common reason for PSA elevation
is Prostatitis, not Prostate Cancer.
Dr. Wheeler presented additional research data at the National Institute of Health (NIH), that showed men with voiding
symptoms reflected Prostatitis primarily, not prostate enlargement (BPH) as traditionally thought. Furthermore, Dr.
Wheeler established that a PSA range of 0-4 ng/ml is not normal, but rather common, as 20-30% of prostate cancers are
noted in this range. Thus, patients are encouraged to know their PSA number and advised that PSA greater than one is
abnormal and unhealthy.
If we change nothing as traditionalists, Prostatitis, BPH and Prostate Cancer will impact the quality of life and life
itself for virtually every American male.
At The Prostatitis and Prostate Cancer Center, we have "zero tolerance for prostate disease". Additional information may
be obtained on the clinic by logging on at www.TheProstateCenter.com.
|
